参考文献(上下滑动查看) 1. 中国 1 型糖尿病胰岛素治疗指南 [J]. 中华糖尿病杂志,2016,8(10):591-597.2. 成人 2 型糖尿病基础胰岛素临床应用中国专家指导建议(2020 版)[J]. 中国糖尿病杂志,2020,28(10):721-728.3. 基层 2 型糖尿病胰岛素应用专家共识 [J]. 中华全科医师杂志,2021,20(07):726-736.4. 2 型糖尿病短期胰岛素强化治疗临床专家指导意见 [J]. 药品评价,2017,14(09):5-12+26. 5. 预混胰岛素临床应用专家共识 (2016 年版)[J]. 药品评价,2016,13(09):5-11. 6. 德谷门冬双胰岛素临床应用专家指导意见 [J]. 中华糖尿病杂志,2021,13(07):695-701. 7. 李玉玲, 唐欢, 唐云辉, 等. 德谷胰岛素在糖尿病治疗中的应用进展 [J]. 山东医药,2020,60(24):104-108. 8. Davies MJ,Gross JL,Ono Y,et al.Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes:a 26-week randomized,open-label,treat-to-target non-inferiority trial[J].Diabetes Obes Metab,2014,16(10):922-930. 9. Lane W, Bailey TS, Gerety G, et al. Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial. JAMA. 2017;318(1):33-44. 10. Siegmund T, Tentolouris N, Knudsen ST, et al. A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes. Diabetes Obes Metab. 2018;20(3):689-697. 11. Zhang XW, Zhang XL, Xu B, et al. Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes:a meta-analysis of randomized controlled trials[J]. Acta Diabetologica, 2018, 55(5):429-441.